Stock-Based Compensation

€16.80M

Quarterly · Period ending: Jun 30, 2026 · EUR

Latest reported€16.80M EURperiod endingJun 30, 2026

ABVX Quarterly Stock-Based Comp · EUR (€0.00 → €16.80M)

Quarterly stock-based compensation

High-resolution chart · PNG

ABVX stock-based compensation history

Quarterly · EUR. Dates are reporting period ends; fiscal years can differ from calendar years.

Abivax S.A. Stock-Based Compensation — Quarterly (EUR)
Period ending	Stock-Based Compensation (EUR)
Jun 30, 2026	16,800,000
Dec 31, 2025	-11,021,000
Jun 30, 2025	6,332,000
Dec 31, 2024	4,689,000
Jun 30, 2024	5,666,000
Dec 31, 2023	0
Jun 30, 2023	56,000
Dec 31, 2022	262,000
Jun 30, 2022	0
Dec 31, 2021	0
Jun 30, 2021	0
Dec 31, 2020	0
Jun 30, 2020	0
Dec 31, 2019	0
Jun 30, 2019	0
Dec 31, 2018	0
Jun 30, 2018	0
Dec 31, 2017	0
Jun 30, 2017	0
Dec 31, 2016	0
Jun 30, 2016	0
Dec 31, 2015	0
Jun 30, 2015	0
Dec 31, 2014	0
Jun 30, 2014	0